Tag: Implantable Cardioverter Defibrillator (ICD)
1. The subcutaneous implantable cardioverter-defibrillator (ICD) was shown to be noninferior to the transvenous ICD for device-related complications in patients with an indication for ICD therapy but not for pacing therapy.
2. The risk of inappropriate shocks was not significantly different between groups, but trended towards increased risk in the...
1. In this multicenter, longitudinal, serial cross-sectional analysis, there were 457 hospitals across 43 states that reached a monetary settlement with the Department of Justice (DOJ) totalling more than $250 million.
2. Following the announcement of the investigation, there were significant reductions in the number of primary implantable cardioverter-defibrillators (ICDs)...
1. Adults with chronic kidney disease (CKD) and heart failure with reduced LVEF who received implantable cardioverter defibrillators (ICDs) did not differ from matched non-ICD patients with relation to all-cause mortality.
2. However, ICD placement in patients with CKD was associated with increased risk of heart failure-related and any-cause hospitalization.
Evidence...
1. Patients with ICD therapy had an overall reduction in all-cause mortality compared to conventional care.
2. The rate of sudden death was decreased in ICD patients.
Evidence Rating Level: 1 (Excellent)
Study Rundown: Implantable cardioverter defibrillators (ICD) are currently used to prevent sudden death in patients with ventricular arrhythmias. Studies have...
1. This prospective cohort study of patients with cardiac pacemakers or implantable cardioverter-defibrillators (ICDs) undergoing magnetic resonance imaging (MRI) demonstrated no deaths, episodes of lead failure requiring immediate replacement, or loss of capture.
2. No adverse events were reported with repeated MRI scans.
Evidence Rating Level: 2 (Good)
Study Rundown: There...
1. No significant difference in overall mortality was found between the implantable cardioverter-defibrillator (ICD) group and the control group.
2. A significant difference in sudden cardiac death was found between the ICD group and the control group.
Evidence Rating Level: 1 (Excellent)
Study Rundown: The benefit of ICDs has been well validated...
1. In patients with congestive heart failure (CHF) and reduced ejection fraction, mortality was significantly lower in patients who received an implantable cardioverter-defibrillator (ICD) compared those who did not receive one.
2. In these patients, amiodarone did not confer a favorable survival benefit as compared to placebo.
Original Date of Publication:...